enVVeno MedicalNVNO
Market Cap: $64.7M
About: enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Employees: 31
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
1,516% more call options, than puts
Call options by funds: $517K | Put options by funds: $32K
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
0.07% more ownership
Funds ownership: 28.09% [Q1] → 28.16% (+0.07%) [Q2]
3% less capital invested
Capital invested by funds: $20.4M [Q1] → $19.7M (-$649K) [Q2]
22% less funds holding
Funds holding: 32 [Q1] → 25 (-7) [Q2]
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Research analyst outlook
We haven’t received any recent analyst ratings for NVNO.
Financial journalist opinion
We haven’t received any recent news articles for NVNO.